| CYHB2401868 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-11-12 | | Beijing SL Pharmaceutical Co Ltd | | | view |
| CYHB2401551 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-09-25 | | Tipr Pharmaceutical Co Ltd | | | view |
| CYHS2402846 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Generic Drug | 2024-08-30 | | Bayer Healthcare Company Ltd | | | view |
| CYHS2402844 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Generic Drug | 2024-08-30 | | Bayer Healthcare Company Ltd | | | view |
| CYHS2402845 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Generic Drug | 2024-08-30 | | Bayer Healthcare Company Ltd | | | view |
| CYHS2402843 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Generic Drug | 2024-08-30 | | Bayer Healthcare Company Ltd | | | view |
| CYHB2401348 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-08-30 | | Nanjing Hicin Pharmaceutical Co Ltd | | | view |
| JYHZ2400220 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(5.1) | License Renew | 2024-08-09 | | | | | view |
| CYHB2401164 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-08-01 | | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | | | view |
| JYHB2400348 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs | Supplementary Application | 2024-07-08 | | Bayer AG | | | view |
| CYHB2400801 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-06-12 | | Suzhou Dawnrays Pharmaceutical Co Ltd | | | view |
| CYHB2400802 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-06-12 | | Suzhou Dawnrays Pharmaceutical Co Ltd | | | view |
| CYHB2400417 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-03-25 | | | | | view |
| CYHB2400205 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-02-05 | | | | | view |
| JYHB2300749 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs | Supplementary Application | 2023-12-28 | | Bayer AG | | | view |
| JYHB2300751 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs | Supplementary Application | 2023-12-28 | | Bayer AG | | | view |
| JYHB2300750 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs | Supplementary Application | 2023-12-28 | | Bayer AG | | | view |
| JYHB2300752 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs | Supplementary Application | 2023-12-28 | | Bayer AG | | | view |
| CYHB2302719 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Supplementary Application | 2023-12-14 | | Jilin Boda Pharmaceutical Co Ltd | | | view |
| CYHB2302720 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Supplementary Application | 2023-12-14 | | Jilin Boda Pharmaceutical Co Ltd | | | view |
